Partnership
Development of targeted therapies and precision medicine
05/20/2016
Our latest press releases and news.
Partnership
A promising program in immunotherapy
03/29/2016
DNA Thearpeutics was acquired in 2016 by ONXEO. First-in-class, signal-interfering DNA molecule based on one of the most promising new approaches in cancer treatment
www.onxeo.com
Innovation
The DBAIT success story
03/02/2016
Partnership
Microbrain Biotech signs an exclusive license to develop neuronal screening with Institut Curie, CNRS and UPMC
02/11/2016
Partnership
CREATION OF A RESEARCH CHAIR IN IMMUNOTHERAPY AT INSTITUT CURIE
12/07/2015
Partnership
Institut Curie and Inventiva launch the Epicure project
03/01/2015
Innovation
Gynecological cancers: an alliance to develop a new antibody
12/16/2014
Partnership
Institut Curie and Sanofi join forces in research on ovarian cancer
06/19/2013
Partnership
Institut Curie and Biolog-id sign partnership agreement to develop a traceability system for cancer chemotherapy preparations
06/04/2013
global care
global care
Partnership
Creation of the Global Care consortium by the Carnot institutes
02/28/2013